Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes

Armitage, L. H., Stimpson, S. E., Santostefano, K. E., Sui, L., Ogundare, S., Newby, B. N., Castro-Gutierrez, R., Huber, M. K., Taylor, J. P., Sharma, P., Radichev, I. A., Perry, D. J., Fredette, N. C., Savinov, A. Y., Wallet, M. A., Terada, N., Brusko, T. M., Russ, H. A., Chen, J., … Mathews, C. E. (2021). Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.737276
Authors:
Lucas H. Armitage
Scott E. Stimpson
Katherine E. Santostefano
Lina Sui
Similoluwa Ogundare
Brittney N. Newby
Roberto Castro-Gutierrez
Mollie K. Huber
Jared P. Taylor
Prerana Sharma
Ilian A. Radichev
Daniel J. Perry
Natalie C. Fredette
Alexei Y. Savinov
Mark A. Wallet
Naohiro Terada
Todd M. Brusko
Holger A. Russ
Jing Chen
Dieter Egli
Clayton E. Mathews
Affiliated Authors:
Lina Sui
Dieter Egli
Author Keywords:
type 1 diabetes mellitus
isogenic
human
beta cells
immunity
autoimmunity
induced pluripotent stem cells
Publication Type:
Article
Unique ID:
10.3389/fendo.2021.737276
Publication Date:
Data Source:
Scopus

Record Created: